| Part Of FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 3

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson… read more

The Food and Drug Administration (FDA) held a virtual open meeting to discuss emergency use authorization for the Johnson & Johnson COVID-19 vaccine. Janssen Biotech, which is the pharmaceutical division of Johnson & Johnson, presented the data from its vaccine study. Discussed were the efficacy of the vaccine, the importance of delivering a one-dose versus a two-dose vaccine, side effects experienced by study participants, and possible complications related to unmasking trial participants. This was the third portion of the daylong advisory board hearing. close

Report Video Issue

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.

You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.

People in this video

  • Mike Kaczynski Project Manager U.S. Food and Drug Administration
  • David Kim Director Centers for Disease Control and Prevention->Immunization Division
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Paul Offit M.D. Chief Children's Hospital of Philadelphia->Division of Infectious Diseases
  • Gregory Poland M.D. Director Mayo Clinic->Vaccine Research Group
  • Hanneke Schuitemaker Global Head Johnson & Johnson->Viral Vaccine Discovery
  • Johan Van Hoof M.D. Head Janssen Research and Development->Global Therapeutic Area
  • Roland Zahn Senior Scientific Director Janssen Pharmaceuticals->Viral Vaccines
More People

Hosting Organization

More Videos From

FDA Advisory Committee Unanimously Approves Johnson & Johnson COVID-19 Vaccine

More Videos
More information about

FDA Open Meeting on Johnson & Johnson COVID-19 Vaccine, Part 3

124 Views
Program ID:
509043-4
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Feb 26, 2021 | 11:10am EST | C-SPAN 2
Last Aired:
Feb 26, 2021 | 10:59pm EST | C-SPAN 2

Airing Details

  • Feb 26, 2021 | 11:10am EST | C-SPAN 2
  • Feb 26, 2021 | 11:27am EST | C-SPAN 2
  • Feb 26, 2021 | 10:59pm EST | C-SPAN 2